PRI analysis suggests billions in savings via biosimilars
A new Pacific Research Institute study estimates that state employee health plans could save up to $1.8 billion annually by expanding the use of lower-cost biosimilar medicines.
A new Pacific Research Institute study estimates that state employee health plans could save up to $1.8 billion annually by expanding the use of lower-cost biosimilar medicines.